SHANGHAI, China, Aug. 7 /Xinhua-EMWNews/ -- Aamaxan

Transport Group, Inc. (the "Company" or "ATG") (OTC Bulletin Board: AAXT),

through its subsidiaries, including Shanghai Medical Technology Co., Ltd.

("Shanghai Medical"), a PRC company and a leading provider of Hemodialysis

equipment ("HDE") and other related supplies and services, including

disposable and diagnostic products, throughout Eastern China, today

announced the appointment of Mr. Xu Yifei as the company's chief financial

officer effective August 1, 2008.



    For the last six years Mr. Xu has served as Vice President and Chief

Operating Officer of Shanghai Medical. Mr. Xu obtained two degrees,

including a major in both finance and internal controls, which were earned

from Shanghai University of Finance and Economics, and from Shanghai

Commerce accounting college in Shanghai PRC, respectively.



    Mr. Xu assumed the position as the Company's CFO on August 1, 2008 and

will report directly to Mr. Chen Zhong, CEO of Shanghai Medical. Mr. Xu

will be responsible for all financial reporting activities, in addition to

managing the Company's overall financial planning and control activities.



    "Mr. Xu will be an integral part of our management team, especially as

we seek to increase transparency, raise our corporate governance standards

and gain more exposure in the US investment community," commented Mr. Chen.

"I am eager to continue working with Mr. Chen in my new role as CFO to

accomplish Shanghai Medical's goals as a US listed public company," stated

Mr. Xu.

    About Shanghai Medical Technology Co., Ltd.



    Shanghai Medical is a leading provider of Hemodialysis and renal care

equipment, supplies, and related support services in Eastern China.

Specifically, Shanghai Medical distributes and sells Hemodialysis equipment

("HDE") which is mainly used by hospitals and medical facilities and

includes machines, dialyzers, disposables and diagnostic products used in

Hemodialysis, throughout the People's Republic of China.



    Cautionary Statement Regarding Forward Looking Information



    This press release may contain forward-looking information about the

Company, Asian Group Management Group Ltd and Shanghai Medical. Forward-

looking statements are statements that are not historical facts. These

statements can be identified by the use of forward-looking terminology such

as "believe," "expect," "may," "will," "should," "project," "plan," "seek,"

"intend," or "anticipate" or the negative thereof or comparable

terminology, and statements which may include discussions of strategy, and

statements about industry trends future performance, operations and

products of each of the entities referred to above. Actual performance

results may vary significantly from expectations and projections as a

result of various factors, including without limitation and the risks set

forth "Risk Factors" contained in the Company's Current Report on Form 8-K

filed on April 21, 2008.



    The shares of common stock issued in connection with the transactions

have not been registered under the Securities Act of 1933, as amended, and

may not be offered or sold in the United States absent registration under

the Securities Act and applicable state securities laws or an applicable

exemption from those registration requirements. The Company has agreed to

file a registration statement covering the resale of the shares of common

stock issued in the private placement and certain other shares, within 45

days of closing.



    This press release does not constitute an offer to sell or the

solicitation of an offer to buy any of the securities referenced herein in

any jurisdiction to any person.






    For more information, please contact:



    For the Company:

     Mr. Chen Zhong, CEO and Chairman

     Email: [email protected]



    Investor Relations:

     HC International, Inc.

     Ted Haberfield, Executive VP

     Phone: +1-760-755-2716

     Email: [email protected]